ST
ARNA

Spot Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Spot Trading’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-250
Closed -$5K – 4167
2015
Q4 		$5K Hold
250
– – ﹤0.01% 3411
2015
Q3 		$5K Sell
250
-880
-78% -$29.9K ﹤0.01% 3701
2015
Q2 		$52K Sell
1,130
-24,340
-96% -$1.06M ﹤0.01% 3274
2015
Q1 		$1.11M Buy
25,470
+20,970
+466% +$975K 0.01% 1513
2014
Q4 		$156K Buy
4,500
+370
+9% +$15K ﹤0.01% 3055
2014
Q3 		$173K Buy
4,130
+3,060
+286% +$137K ﹤0.01% 3265
2014
Q2 		$63K Sell
1,070
-39,470
-97% -$2.49M ﹤0.01% 3864
2014
Q1 		$2.55M Buy
40,540
+19,100
+89% +$1.27M 0.01% 1310
2013
Q4 		$1.25M Buy
21,440
+18,260
+574% +$954K 0.01% 1813
2013
Q3 		$168K Sell
3,180
-16,270
-84% -$1.09M ﹤0.01% 3130
2013
Q2 		$1.5M Buy
+19,450
New +$1.59M 0.01% 1610

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Spot Trading's ARNA Position: Q1 2016 in Review

Spot Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2016, closing a stake of 1,105 shares — an estimated $21K sold.

Spot Trading first reported a position in ARNA in Q3 2013 and held it in 8 quarters. The position peaked at $258K in Q4 2014. 111 funds tracked by Wall St. Rank hold ARNA as of Q1 2016.

  • Spot Trading reported no remaining Arena Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 1,105 Arena Pharmaceuticals Inc shares in Q1 2016, an estimated $21K.
  • Spot Trading first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
  • Spot Trading's Arena Pharmaceuticals Inc position peaked at $258K in Q4 2014.
  • 111 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.